← Leaderboards
Charles Jr Parker Gibbs
University Of Florida
$1,791,866
Attributed
$1,791,866
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $304K · FY2006–15$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,791,866 · 2
By mechanism
R01$1,492,581 · 1
R21$299,285 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Martin J Cohn$11,032,265
- Maryam Rahman$1,071,900
- Guangbin Xia$669,429
- Laura Padilla$155,545
- Elias Sayour$8,823,629
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorCancer Stem CellMalignant NeoplasmsTumorigenicOperative Surgical ProceduresInsightGenesLinkOsteosarcomaTumorigenesisSurvival RateCellsBaseChemotherapyAdolescenceEffective TherapyEndoplasmic Reticulum StressAutomobile DrivingBoneAlgorithmsEpigenetic ProcessCell TypeCellular StressBiology
Grant awards (7)
Intra-tumoral Heterogeneity in Osteosarcoma: Tumorigenicity & Malignant Revision$303,988
R01 · FY2015 · CA · contact PI
Intra-tumoral Heterogeneity in Osteosarcoma: Tumorigenicity & Malignant Revision$294,868
R01 · FY2014 · CA · contact PI
Intra-tumoral Heterogeneity in Osteosarcoma: Tumorigenicity & Malignant Revision$285,749
R01 · FY2013 · CA · contact PI
Intra-tumoral Heterogeneity in Osteosarcoma: Tumorigenicity & Malignant Revision$303,988
R01 · FY2012 · CA · contact PI
Intra-tumoral Heterogeneity in Osteosarcoma: Tumorigenicity & Malignant Revision$303,988
R01 · FY2011 · CA · contact PI
STEM-LIKE CELLS AND TUMORGENICITY IN OSTEOSARCOMA$161,060
R21 · FY2007 · CA · contact PI
STEM-LIKE CELLS AND TUMORGENICITY IN OSTEOSARCOMA$138,225
R21 · FY2006 · CA · contact PI